376 related articles for article (PubMed ID: 27981602)
1. Prohibitin 1 suppresses liver cancer tumorigenesis in mice and human hepatocellular and cholangiocarcinoma cells.
Fan W; Yang H; Liu T; Wang J; Li TW; Mavila N; Tang Y; Yang J; Peng H; Tu J; Annamalai A; Noureddin M; Krishnan A; Gores GJ; Martínez-Chantar ML; Mato JM; Lu SC
Hepatology; 2017 Apr; 65(4):1249-1266. PubMed ID: 27981602
[TBL] [Abstract][Full Text] [Related]
2. Deregulated methionine adenosyltransferase α1, c-Myc, and Maf proteins together promote cholangiocarcinoma growth in mice and humans(‡).
Yang H; Liu T; Wang J; Li TW; Fan W; Peng H; Krishnan A; Gores GJ; Mato JM; Lu SC
Hepatology; 2016 Aug; 64(2):439-55. PubMed ID: 26969892
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.
Liu T; Yang H; Fan W; Tu J; Li TWH; Wang J; Shen H; Yang J; Xiong T; Steggerda J; Liu Z; Noureddin M; Maldonado SS; Annamalai A; Seki E; Mato JM; Lu SC
Gastroenterology; 2018 Aug; 155(2):557-571.e14. PubMed ID: 29733835
[TBL] [Abstract][Full Text] [Related]
4. Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice.
Ko KS; Tomasi ML; Iglesias-Ara A; French BA; French SW; Ramani K; Lozano JJ; Oh P; He L; Stiles BL; Li TW; Yang H; Martínez-Chantar ML; Mato JM; Lu SC
Hepatology; 2010 Dec; 52(6):2096-108. PubMed ID: 20890892
[TBL] [Abstract][Full Text] [Related]
5. Generation of combined hepatocellular-cholangiocarcinoma through transdifferentiation and dedifferentiation in p53-knockout mice.
Liu Y; Xin B; Yamamoto M; Goto M; Ooshio T; Kamikokura Y; Tanaka H; Meng L; Okada Y; Mizukami Y; Nishikawa Y
Cancer Sci; 2021 Aug; 112(8):3111-3124. PubMed ID: 34051011
[TBL] [Abstract][Full Text] [Related]
6. Hepatic prohibitin 1 and methionine adenosyltransferase α1 defend against primary and secondary liver cancer metastasis.
Fan W; Cao D; Yang B; Wang J; Li X; Kitka D; Li TWH; You S; Shiao S; Gangi A; Posadas E; Di Vizio D; Tomasi ML; Seki E; Mato JM; Yang H; Lu SC
J Hepatol; 2024 Mar; 80(3):443-453. PubMed ID: 38086446
[TBL] [Abstract][Full Text] [Related]
7. Differential Expression of Sonic Hedgehog Protein in Human Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Al-Bahrani R; Nagamori S; Leng R; Petryk A; Sergi C
Pathol Oncol Res; 2015 Sep; 21(4):901-8. PubMed ID: 25740074
[TBL] [Abstract][Full Text] [Related]
8. Annexin A1: A new immunohistological marker of cholangiocarcinoma.
Hongsrichan N; Rucksaken R; Chamgramol Y; Pinlaor P; Techasen A; Yongvanit P; Khuntikeo N; Pairojkul C; Pinlaor S
World J Gastroenterol; 2013 Apr; 19(16):2456-65. PubMed ID: 23674846
[TBL] [Abstract][Full Text] [Related]
9. A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression.
Yang H; Li TW; Peng J; Tang X; Ko KS; Xia M; Aller MA
Gastroenterology; 2011 Jul; 141(1):378-88, 388.e1-4. PubMed ID: 21440549
[TBL] [Abstract][Full Text] [Related]
10. The mitochondrial chaperone Prohibitin 1 negatively regulates interleukin-8 in human liver cancers.
Yang JW; Murray B; Barbier-Torres L; Liu T; Liu Z; Yang H; Fan W; Wang J; Li Y; Seki E; Mato JM; Lu SC
J Biol Chem; 2019 Feb; 294(6):1984-1996. PubMed ID: 30523154
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal Regulation Between Forkhead Box M1/NF-κB and Methionine Adenosyltransferase 1A Drives Liver Cancer.
Li Y; Lu L; Tu J; Zhang J; Xiong T; Fan W; Wang J; Li M; Chen Y; Steggerda J; Peng H; Chen Y; Li TWH; Zhou ZG; Mato JM; Seki E; Liu T; Yang H; Lu SC
Hepatology; 2020 Nov; 72(5):1682-1700. PubMed ID: 32080887
[TBL] [Abstract][Full Text] [Related]
12. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
13. Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.
Zhang H; Li Z; Chu B; Zhang F; Zhang Y; Ke F; Chen Y; Xu Y; Liu S; Zhao S; Liang H; Weng M; Wu X; Li M; Wu W; Quan Z; Liu Y; Zhang Y; Gong W
Tumour Biol; 2016 Jun; 37(6):8305-15. PubMed ID: 26729195
[TBL] [Abstract][Full Text] [Related]
14. Differential SIRT1 expression in hepatocellular carcinomas and cholangiocarcinoma of the liver.
Al-Bahrani R; Tuertcher D; Zailaie S; Abuetabh Y; Nagamori S; Zetouni N; Bahitham W; Sergi C
Ann Clin Lab Sci; 2015; 45(1):3-9. PubMed ID: 25696003
[TBL] [Abstract][Full Text] [Related]
15. Activation of a novel c-Myc-miR27-prohibitin 1 circuitry in cholestatic liver injury inhibits glutathione synthesis in mice.
Yang H; Li TW; Zhou Y; Peng H; Liu T; Zandi E; Martínez-Chantar ML; Mato JM; Lu SC
Antioxid Redox Signal; 2015 Jan; 22(3):259-74. PubMed ID: 25226451
[TBL] [Abstract][Full Text] [Related]
16. Loss of ezrin in human intrahepatic cholangiocarcinoma is associated with ectopic expression of E-cadherin.
Guedj N; Vaquero J; Clapéron A; Mergey M; Chrétien Y; Paradis V; Fouassier L
Histopathology; 2016 Aug; 69(2):211-21. PubMed ID: 26791814
[TBL] [Abstract][Full Text] [Related]
17. E3 ubiquitin ligase FBW7α inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E.
Li M; Ouyang L; Zheng Z; Xiang D; Ti A; Li L; Dan Y; Yu C; Li W
Oncol Rep; 2017 Mar; 37(3):1627-1636. PubMed ID: 28184929
[TBL] [Abstract][Full Text] [Related]
18. Periostin, a matrix protein, has potential as a novel serodiagnostic marker for cholangiocarcinoma.
Fujimoto K; Kawaguchi T; Nakashima O; Ono J; Ohta S; Kawaguchi A; Tonan T; Ohshima K; Yano H; Hayabuchi N; Izuhara K; Sata M
Oncol Rep; 2011 May; 25(5):1211-6. PubMed ID: 21347516
[TBL] [Abstract][Full Text] [Related]
19. Prohibitin 1 Regulates the H19-Igf2 Axis and Proliferation in Hepatocytes.
Ramani K; Mavila N; Ko KS; Mato JM; Lu SC
J Biol Chem; 2016 Nov; 291(46):24148-24159. PubMed ID: 27687727
[TBL] [Abstract][Full Text] [Related]
20. Methionine adenosyltransferases in liver cancer.
Murray B; Barbier-Torres L; Fan W; Mato JM; Lu SC
World J Gastroenterol; 2019 Aug; 25(31):4300-4319. PubMed ID: 31496615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]